GALNT17
Polypeptide N-acetylgalactosaminyltransferase 17
Also known as: GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, GLT17_HUMAN, ppGalNAc-T17, WBSCR17
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6IS24
- Gene
- GALNT17
- Ensembl
- ENSG00000185274
- Chromosome
- 7
- Canonical length
- 598 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus
OverviewNCBI Gene
This gene encodes an N-acetylgalactosaminyltransferase. This gene is located centromeric to the common deleted region in Williams-Beuren syndrome (WBS), a multisystem developmental disorder caused by the deletion of contiguous genes at 7q11.23. This protein may play a role in membrane trafficking. [provided by RefSeq, Jan 2013]
Canonical amino-acid sequenceUniProt
598 residues, UniProt reviewed canonical sequence.
>Q6IS24|GALNT17
1 MASLRRVKVL LVLNLIAVAG FVLFLAKCRP IAVRSGDAFH EIRPRAEVAN LSAHSASPIQ
61 DAVLKRLSLL EDIVYRQLNG LSKSLGLIEG YGGRGKGGLP ATLSPAEEEK AKGPHEKYGY
121 NSYLSEKISL DRSIPDYRPT KCKELKYSKD LPQISIIFIF VNEALSVILR SVHSAVNHTP
181 THLLKEIILV DDNSDEEELK VPLEEYVHKR YPGLVKVVRN QKREGLIRAR IEGWKVATGQ
241 VTGFFDAHVE FTAGWAEPVL SRIQENRKRV ILPSIDNIKQ DNFEVQRYEN SAHGYSWELW
301 CMYISPPKDW WDAGDPSLPI RTPAMIGCSF VVNRKFFGEI GLLDPGMDVY GGENIELGIK
361 VWLCGGSMEV LPCSRVAHIE RKKKPYNSNI GFYTKRNALR VAEVWMDDYK SHVYIAWNLP
421 LENPGIDIGD VSERRALRKS LKCKNFQWYL DHVYPEMRRY NNTVAYGELR NNKAKDVCLD
481 QGPLENHTAI LYPCHGWGPQ LARYTKEGFL HLGALGTTTL LPDTRCLVDN SKSRLPQLLD
541 CDKVKSSLYK RWNFIQNGAI MNKGTGRCLE VENRGLAGID LILRSCTGQR WTIKNSIKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GALNT17 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 65 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 65 nTPM
- cerebellum: 63 nTPM
- choroid plexus: 60 nTPM
- hippocampal formation: 44 nTPM
- heart muscle: 41 nTPM
- amygdala: 31 nTPM
Single-cell type
- choroid plexus epithelial cells: 1,724 nCPM
- thyrotrophs: 1,224 nCPM
- renal collecting duct intercalated cells: 1,060 nCPM
- lactotrophs: 759 nCPM
- somatotrophs: 730 nCPM
- cardiomyocytes: 730 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hippocampal formation: 152 nTPM
- cerebral cortex: 143 nTPM
- choroid plexus: 136 nTPM
- cerebellum: 109 nTPM
- basal ganglia: 98 nTPM
- white matter: 86 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0.12
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GALNT17 as an antibody target. Whether an autoantibody or antibody against GALNT17 could matter depends on whether native GALNT17 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GALNT17 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GALNT17 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...